You are here

  • Home
  • Archive
  • Volume 22, Issue 5
  • Gemcitabine for Advanced Endometrial Cancer: A Retrospective Study of the Memorial Sloan-Kettering Cancer Center Experience

Article info

Article menu
Download PDFPDF
Uterine Cancer
Gemcitabine for Advanced Endometrial Cancer: A Retrospective Study of the Memorial Sloan-Kettering Cancer Center Experience

Authors

  1. Address correspondence and reprint requests to Jason Konner, MD, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065. E-mail: gynbreast@mskcc.org.

Citation

Grisham RN, Adaniel C, Hyman DM, et al
Gemcitabine for Advanced Endometrial Cancer: A Retrospective Study of the Memorial Sloan-Kettering Cancer Center Experience
International Journal of Gynecologic Cancer 2012;22:807-811.

Publication history

  • Received September 29, 2011
  • First published June 1, 2012.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright © 2012 by IGCS and ESGO